Healthy Skepticism Library item: 4139

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

MaLAM Letter follow up—were “brain tonic” results just a stroke of luck?
MaLAM Newsletter 1990 Apr

Abstract:

Farmitalia Carlo Erba has not responded to MaLAM’s letter about the promotion of nicergoline but the company has provided MaLAM with copies of a study. This report does not answer MaLAM’s concerns.

Keywords:
*analysis/nicergoline/Farmitalia Carlo Erba/company responses/neurologic drugs/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/EVALUATION OF PROMOTION: GENERAL QUALITY OF INFORMATION/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: NEUROLOGIC DISEASES/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES